These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31918780)

  • 21. Understanding the cryptic nature of Lassa fever in West Africa.
    Gibb R; Moses LM; Redding DW; Jones KE
    Pathog Glob Health; 2017 Sep; 111(6):276-288. PubMed ID: 28875769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria.
    Ochu CL; Ntoimo L; Onoh I; Okonofua F; Meremikwu M; Mba S; Iniobong A; Nwafor O; Dalhat M; Ohonsi C; Arinze C; Esu E; Igumbor EU; Dan-Nwafor C; Ilori E; Adetifa I
    Sci Rep; 2023 Apr; 13(1):6545. PubMed ID: 37085507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in Lassa Fever Cases in Nigeria, January-March 2018.
    Ilori EA; Frank C; Dan-Nwafor CC; Ipadeola O; Krings A; Ukponu W; Womi-Eteng OE; Adeyemo A; Mutbam SK; Musa EO; Lasuba CLP; Alemu W; Okogbenin S; Ogbaini E; Unigwe U; Ogah E; Onoh R; Abejegah C; Ayodeji O; Ihekweazu C
    Emerg Infect Dis; 2019 May; 25(5):1026-1027. PubMed ID: 30807268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge of Lassa fever and use of infection prevention and control facilities among health care workers during Lassa fever outbreak in Ondo State, Nigeria.
    Ijarotimi IT; Ilesanmi OS; Aderinwale A; Abiodun-Adewusi O; Okon IM
    Pan Afr Med J; 2018; 30():56. PubMed ID: 30197747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden.
    Mateer EJ; Huang C; Shehu NY; Paessler S
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006187. PubMed ID: 29470486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early onset of neurological features differentiates two outbreaks of Lassa fever in Ebonyi state, Nigeria during 2017-2018.
    Chika-Igwenyi NM; Harrison RE; Psarra C; Gil-Cuesta J; Gulamhusein M; Onwe EO; Onoh RC; Unigwe US; Ajayi NA; Nnadozie UU; Ojide CK; Nwidi DU; Ezeanosike O; Sampson E; Adeke AS; Ugwu CN; Anebonam U; Tshiang JK; Maikere J; Reid A
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009169. PubMed ID: 33684118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of Lassa Fever and Factors Associated with Deaths, Bauchi State, Nigeria, 2015-2018.
    Abdulkarim MA; Babale SM; Umeokonkwo CD; Bamgboye EA; Bashorun AT; Usman AA; Balogun MS
    Emerg Infect Dis; 2020 Apr; 26(4):799-801. PubMed ID: 32186504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lassa fever outbreaks in Nigeria.
    Akpede GO; Asogun DA; Okogbenin SA; Okokhere PO
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):663-666. PubMed ID: 30111178
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence and outcome of Lassa fever among hospitalized patients in Ebonyi State, Nigeria, 2018-2019.
    Nwafor IE; Ogah OE; Ojide CK; Odeh EC; Abu AM; Chika-Igwenyi NM; Nwidi DU; Unigwe US; Ajayi NA; Eke MAS; Obasi MN; Adeke AS; Onyia V; Duruiheoma R; Igboke NC; Otti J; Ogbu O
    Virus Res; 2020 Aug; 285():198000. PubMed ID: 32380207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A neutralization test survey for Lassa Fever activity in Lassa, Nigeria.
    Arnold RB; Gary GW
    Trans R Soc Trop Med Hyg; 1977; 71(2):152-4. PubMed ID: 560072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lassa virus infection in Nigeria: clinical perspective overview.
    Idemyor V
    J Natl Med Assoc; 2010 Dec; 102(12):1243-6. PubMed ID: 21287906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study.
    Chandra NL; Bolt H; Dan-Nwafor C; Ipadeola O; Ilori E; Namara G; Olayinka AT; Ukponu W; Iniobong A; Amedu M; Akano A; Akabike KO; Okhuarobo U; Fagbemi S; Sampson E; Newitt S; Verlander NQ; Bausch DG; le Polain de Waroux O; Ihekweazu C
    BMC Infect Dis; 2021 Feb; 21(1):143. PubMed ID: 33541278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential for Seasonal Lassa Fever Case Exportation from Nigeria.
    Tuite AR; Watts AG; Kraemer MUG; Khan K; Bogoch II
    Am J Trop Med Hyg; 2019 Mar; 100(3):647-651. PubMed ID: 30693858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outbreak of lassa fever in Nigeria: measures for prevention and control.
    Mofolorunsho KC
    Pan Afr Med J; 2016; 23():210. PubMed ID: 27347299
    [No Abstract]   [Full Text] [Related]  

  • 35. Inter-State Transmission of Lassa Fever during the 2015-2016 Lassa Outbreak in Nigeria: An Implication for Infection Prevention and Control Practices.
    Mohammed Y; Bello UI; Chinaka CC; Onuoha M; Sarki M; Yahaya SS; Suleiman K; Dalhat MM
    West Afr J Med; 2023 Jul; 40(7):684-688. PubMed ID: 37515581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nigeria hit by unprecedented Lassa fever outbreak.
    Roberts L
    Science; 2018 Mar; 359(6381):1201-1202. PubMed ID: 29590055
    [No Abstract]   [Full Text] [Related]  

  • 37. Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017.
    Okoro OA; Bamgboye E; Dan-Nwafor C; Umeokonkwo C; Ilori E; Yashe R; Balogun M; Nguku P; Ihekweazu C
    Pan Afr Med J; 2020; 37():15. PubMed ID: 33062117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.
    Dan-Nwafor CC; Furuse Y; Ilori EA; Ipadeola O; Akabike KO; Ahumibe A; Ukponu W; Bakare L; Okwor TJ; Joseph G; Mba NG; Akano A; Olayinka AT; Okoli I; Okea RA; Makava F; Ugbogulu N; Oladele S; Namara G; Muwanguzi EN; Naidoo D; Mutbam SK; Okudo I; Woldetsadik SF; Lasuba CL; Ihekweazu C
    Euro Surveill; 2019 May; 24(20):. PubMed ID: 31115314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lassa fever cases and mortality in Nigeria: Quantile Regression vs. Machine Learning Models.
    Samson TK; Aromolaran O; Akingbade T
    J Public Health Afr; 2023 Dec; 14(12):2712. PubMed ID: 38259425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.